Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
Revenue for Oramed Pharmaceuticals (ORMP)
Revenue in 2023 (TTM): $1.34 M
According to Oramed Pharmaceuticals's latest financial reports the company's current revenue (TTM
) is $1.34 M.
In 2022 the company made a revenue of $2.7 M a decrease over the years 2021 revenue that were of $2.7 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Oramed Pharmaceuticals from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $1.34 M | -50.43% |
| 2022 | $2.7 M | 0% |
| 2021 | $2.7 M | -0.26% |
| 2020 | $2.71 M | 0.26% |
| 2019 | $2.7 M | 7.6% |
| 2018 | $2.51 M | 2.24% |
| 2017 | $2.45 M | 96.4% |
| 2016 | $1.25 M | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $35.45 B | 2,645,982.28% | 🇩🇰 Denmark |
 Sanofi SNY | $50.51 B | 3,769,567.49% | 🇫🇷 France |
 Ultragenyx RARE | $0.43 B | 32,306.64% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $1.2 M | -10.07% | 🇺🇸 USA |
 Compugen CGEN | $33.45 M | 2,396.94% | 🇮🇱 Israel |